CD274 and non-small cell lung carcinoma: Similarly, multiple clinical trials showed that PD-(L)1 blockade plus Chemo significantly increased MPR and pCR rates in NSCLC (27–30).Mechanistically, chemotherapeutic agents are capable of both direct killing of tumor cells and indirect inhibition of tumor development by promoting the release of tumor antigens to regulate tumor TIME.